C-MYC is overexpressed in many different cancers; L-MYC is most often overexpressed in small cell lung carcinomas, while N-MYC is most frequently overexpressed in solid cancers of neural origin, as neuroblastoma and glioma. Here, MYCN is linked to central nervous system cancer.